1. Home
  2. WASH vs MLYS Comparison

WASH vs MLYS Comparison

Compare WASH & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Washington Trust Bancorp Inc.

WASH

Washington Trust Bancorp Inc.

HOLD

Current Price

$30.21

Market Cap

585.9M

Sector

Finance

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$37.39

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WASH
MLYS
Founded
1800
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.9M
3.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WASH
MLYS
Price
$30.21
$37.39
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$30.25
$47.33
AVG Volume (30 Days)
112.3K
1.5M
Earning Date
01-28-2026
02-11-2026
Dividend Yield
7.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$117,341,000.00
N/A
Revenue This Year
$57.78
N/A
Revenue Next Year
$8.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.95
$8.24
52 Week High
$34.13
$47.65

Technical Indicators

Market Signals
Indicator
WASH
MLYS
Relative Strength Index (RSI) 57.17 44.26
Support Level $30.27 $36.01
Resistance Level $31.48 $38.23
Average True Range (ATR) 0.53 1.77
MACD -0.07 0.07
Stochastic Oscillator 46.41 42.59

Price Performance

Historical Comparison
WASH
MLYS

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: